Document is current
Any future updates will be listed below
-
Authors
Dahal, Subha
Clayton, Kiera
Been, Terek
Fernet-Brochu, Raphaële
Ocando, Alonso Villasmil
Balachandran, Ahalya
Poirier, Mikaël
Maldonado, Rebecca Kaddis
Shkreta, Lulzim
Boligan, Kayluz Frias
Guvenc, Furkan
Rahman, Fariha
Branch, Donald
Bell, Brendan
Chabot, Benoit
Gray-Owen, Scott D.
Parent, Leslie J.
Cochrane, Alan
-
Funding
Funding for this research was provided by:
Canadian Foundation for AIDS Research
Canadian Institutes of Health Research (MOP-13024, PJT-165966, PJT-165966)
National Institutes of Health (F32AI143480, R01GM139392)
- License Information
-
More Information
Article History
Received: 17 March 2022
Accepted: 29 July 2022
First Online: 19 August 2022
Declarations
:
: Written informed consent was obtained from volunteer blood donors in accordance with guidelines for conducting biomedical research and experimental protocols approved by the University of Toronto HIV Research Ethics Board or St. Michael’s Hospital (Toronto, Canada) research ethics committee (REB #12-378). Blood products from anonymous HIV/HCV-uninfected healthy donors were also acquired from the Massachusetts General Hospital Blood Bank. No identifying information (i.e., gender and age) of the donors was available. The institutional review board of Massachusetts General Hospital approved the use of these blood products for research purposes. All human subjects gave written, informed consent for use of their blood products for research purposes.
: All authors have read and agreed to the published version of the manuscript.
: The authors have no competing interests as defined by BMC, or other interests that might be perceived to influence the results and/or discussion reported in this paper.
